Electromagnetic guidance for catheter-based transendocardial injection: A platform for intramyocardial angiogenesis therapy

Journal of the American College of Cardiology

Volumn 35, Issue 4, 2000, Pages 1031-1039

  Kornowski, Ran ^a,b,c   Leon, Martin B ^a,b,c   Fuchs, Shmuel ^a,b,c   Vodovotz, Yoram ^a,b,c   Flynn, Michael A ^b   Gordon, David A ^b   Pierre, Anthony ^a,b,c   Kovesdi, Imre ^c   Keiser, Joan A ^b   Epstein, Stephen E ^a,b,c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b PFIZER INC   (United States)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BETA GALACTOSIDASE; METHYLENE BLUE; VASCULOTROPIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; ENDOCARDIUM; FLUOROSCOPY; GENE EXPRESSION; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART TAMPONADE; HISTOPATHOLOGY; INJECTION; INJECTION SITE; MUSCLE CELL; NEEDLE; NONHUMAN; OPEN HEART SURGERY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SENSOR; SWINE; THREE DIMENSIONAL IMAGING; TRANSGENE; ULTRAVIOLET RADIATION; VIRUS PARTICLE;

ANIMALS; BODY SURFACE POTENTIAL MAPPING; CORONARY CIRCULATION; ENDOCARDIUM; ENDOTHELIAL GROWTH FACTORS; EQUIPMENT DESIGN; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEART CATHETERIZATION; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS; LYMPHOKINES; MYOCARDIAL ISCHEMIA; PERICARDIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034654128     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00642-7     Document Type: Article

References (21)

1. Waltenberger J. Modulation of growth factor action. Implication for the treatment of cardiovascular diseases. Circulation. 96:1997;4083-4094.
2. Unger E.F., Banai S., Shou M., et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:1994;H1588-H1595.
3. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;2183-2189.
4. Lazarous D.F., Scheinowitz M., Shou M., et al. Effect of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 91:1995;145-153.
5. Lazarous D.F., Shou M., Scheinowitz M., et al. Comparative effects of basic development and the arterial response to injury. Circulation. 94:1996;1074-1082.
6. Giordano F.J., Ping P., Mckirnan D., et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2:1996;534-539.
7. Mack C.A., Patel S.R., Schwartz E.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for VEGF/12 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 115:1998;168-176.
8. Schumacher B., Pecher P., von Specht B.U., Stegman T. Induction of neoangiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation. 97:1998;645-650.
9. Losordo D.W., Vale P.R., Symes J.F., et al. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF-165 as sole therapy for myocardial ischemia . Circulation. 98:1998;2800-2804.
10. Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF-121 cDNA to individuals with clinically significant severe coronary artery disease . Circulation. 100:1999;468-474.
11. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 73:1993;1202-1207.
12. Li J.J., Ueno H., Pan Y., et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res. 30:1995;97-105.
13. Ben-Haim S.A., Osadchy D., Schuster I., Gepsetin L., Hayam G., Josephson M.E. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 2:1996;1393-1395.
14. Gepsetin L., Hayam G., Ben-Haim S.A. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation. 95:1997;1611-1622.
15. Kornowski R., Hong M.K., Gepstein L., et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 98:1998;1116-1124.
16. Kornowski R., Hong M.K., Leon M.B. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation. 98:1998;1837-1841.
17. Kornowski R., Hong M.K., Haudenschild C.C., Leon M.B. Feasibility and safety of percutaneous laser revascularization using the Biosense system in porcine hearts. Coronary Artery Dis. 9:1998;535-540.
18. Fuchs S., Kornowski R., Shiran A., Pierre A., Leon M.B. Electromechanical characterization of myocardial hibernation in a pig model. Coronary Artery Dis. 10:1999;195-198.
19. Shen Y.T., Vanter S.F. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Circ Res. 76:1995;479-488.
20. Lazarous D.F., Shou M., Stiber J.A., et al. Pharmacodynamics of basic fibroblast growth factor route of administration determines myocardial and systemic distribution . Cardiovasc Res. 36:1997;78-85.
21. Vale P.R., Losordo D.W., Tkebuchava T., Chen D., Milliken C.E., Isner J. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol. 34:1999;246-254.